Zobrazeno 1 - 10
of 658
pro vyhledávání: '"Edward Ha"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Theoretical biology forum. 113(1-2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::805b3a0f7ccf20b32fbb79c8fb31efcd
https://pubmed.ncbi.nlm.nih.gov/33929004
https://pubmed.ncbi.nlm.nih.gov/33929004
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Figure 1 from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c0d912b911193a89f8c41d6660b15e7
https://doi.org/10.1158/1078-0432.22442970
https://doi.org/10.1158/1078-0432.22442970
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Purpose: Antibody drug conjugates (ADCs) combine the ideal properties of both antibodies and cytotoxic drugs by targeting potent drugs to the antigen-expressing tumor cells, thereby enhancing their antitumor activity. Successful ADC development for a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d28facc06955b3988a108b08483c5b9
https://doi.org/10.1158/1078-0432.c.6519576
https://doi.org/10.1158/1078-0432.c.6519576
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Methods, Figure Legends 1-3, Tables 1A-B from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234fb526b489c22c090c1bc0298163b4
https://doi.org/10.1158/1078-0432.22442958.v1
https://doi.org/10.1158/1078-0432.22442958.v1
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Figure 3C-D from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f44961c6a240c1b49072e5ec02c2e71
https://doi.org/10.1158/1078-0432.22442961
https://doi.org/10.1158/1078-0432.22442961
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Figure 2 from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::780049c9955d6fc471ce12dcf37886bc
https://doi.org/10.1158/1078-0432.22442967
https://doi.org/10.1158/1078-0432.22442967
Autor:
Mark X. Sliwkowski, Paul Polakis, Richard H. Scheller, Susan D. Spencer, Richard Vandlen, Jay Tibbitts, Reina N. Fuji, Hajime Hiraragi, Gail D. Lewis Phillips, Elaine Mai, Guangmin Li, Debra L. Dugger, Trung Nguyen, Sunil Bhakta, Helga Raab, Edward Ha, Kathryn L. Parsons, Richard A. Graham, Kelly M. Flagella, Jagath R. Junutula
Supplementary Figure 3A-B from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecc2f3a7760b11a7fc648936743bf45a
https://doi.org/10.1158/1078-0432.22442964
https://doi.org/10.1158/1078-0432.22442964
Autor:
Ming Lee, Estebes Hernandez, Rachel Brook, Edward Ha, Christina Harris, Monica Plesa, Daniel Kahn
Publikováno v:
MedEdPublish, Vol 7, Iss 3 (2018)
Introduction Medical educators need to demonstrate that their trainees meet expected competency levels when progressing through medical education. This study aimed to develop competency-based pass/fail cut-scores for a graduation required Objectiv
Externí odkaz:
https://doaj.org/article/34ecee764fd74c96a0425f6a567f6874
Publikováno v:
Annals of Hematology. 98:2443-2445
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0282a3924480e3eb9208ae2d4e5b32b9
https://doi.org/10.1007/s00277-019-03780-1
https://doi.org/10.1007/s00277-019-03780-1